Detalhe da pesquisa
1.
A personalized probabilistic approach to ovarian cancer diagnostics.
Gynecol Oncol
; 182: 168-175, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266403
2.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med
; 375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717299
3.
Response to the letter to the editor.
Gynecol Oncol
; 183: 143, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514301
4.
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
Gynecol Oncol
; 155(3): 393-399, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31653510
5.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 19(8): 1117-1125, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026000
6.
Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions.
J Proteome Res
; 14(1): 434-46, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25437919
7.
p66Shc longevity protein regulates the proliferation of human ovarian cancer cells.
Mol Carcinog
; 54(8): 618-31, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24395385
8.
Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.
Gynecol Oncol
; 134(1): 96-103, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24802724
9.
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Int J Gynecol Cancer
; 23(7): 1331-3, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970157
10.
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
Nat Commun
; 13(1): 3385, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697674
11.
Label-free microfluidic enrichment of cancer cells from non-cancer cells in ascites.
Sci Rep
; 11(1): 18032, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504124
12.
Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
Proteomics
; 10(3): 470-81, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19953551
13.
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles.
Nanomedicine
; 6(3): 399-408, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19969103
14.
Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines.
BMC Bioinformatics
; 10: 259, 2009 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19698113
15.
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
J Clin Oncol
; 37(34): 3183-3191, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518175
16.
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
J Clin Oncol
; 37(32): 2968-2973, 2019 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173551
17.
Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors.
Mol Cancer
; 7: 43, 2008 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18498645
18.
Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells.
J Transl Med
; 6: 79, 2008 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19077237
19.
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.
Sci Rep
; 8(1): 16444, 2018 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30401894
20.
Identification of candidate methylation-responsive genes in ovarian cancer.
Mol Cancer
; 6: 10, 2007 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17254359